Navigation Links
Potential Nipah vaccine passes primate test
Date:8/9/2012

Researchers have successfully tested a vaccine for the deadly Nipah virus in monkeys, raising hopes that it could provide similar protection for humans.

With greater than a 75 percent fatality rate and the ability to be transmitted directly from person to person, Nipah has long been a significant concern for infectious-disease experts. The virus, which is carried naturally by fruit bats, was first discovered in Malaysia in 1998. Outbreaks have occurred in nearly every year since, in Singapore, Bangladesh and India.

"This vaccine is based on a protein from Hendra virus, which is a very close relative of Nipah Hendra's found in Australia and is also spread by bats, which give it to horses, which give it to people," said University of Texas Medical Branch at Galveston professor Thomas Geisbert, senior author of a paper on the study now online in Science Translational Medicine. "We've got a lot of confidence that the vaccine will work in people, because the animal model we used in this experiment, the African green monkey, faithfully reproduces all aspects of human Nipah and Hendra disease."

Because there is no approved vaccine or therapy for Nipah, the researchers conducted their study in a biosafety level 4 "spacesuit" facility at the National Institutes of Health's Rocky Mountain Laboratories in Hamilton, Mont. There, the scientists divided nine monkeys into three equal groups, administering a different vaccine dose to each group.

Forty-two days later, the researchers infected the animals with what should have been a lethal dose of Nipah. But all of the vaccinated monkeys even those that had received the lowest dose of the vaccine remained completely healthy.

"The vaccine worked great," Geisbert said.

The researchers plan further studies to prepare for a possible application for review by the Food and Drug Administration to license the vaccine for human use. In addition, the vaccine is now in comm
'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers find potential cancer roadblock
2. Early treatment could mean greater earning potential for people with HIV
3. Rejected Alzheimers drug shows new potential
4. ACR: Medical imaging study in health affairs incomplete and potentially misleading
5. Texas A&M biologists prove ZOLOFT packs potential to fight fungal meningitis
6. Researchers study vaccine as potential weapon against aggressive brain tumors
7. Research shows potential of microneedles to target therapeutics to the back of the eye
8. Moffitt Cancer Center researchers find potential key to new treatment for mantle cell lymphoma
9. Beige Fat Joins Brown Fat as Potential Weight-Loss Target
10. Regulation by proteins outside cancer cells points to potential new drug target
11. BUSM in vitro study identifies potential combination therapy for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... giving patients a long-lasting impression on what modern dentistry ... VisitandCare.com is on a mission to revolutionize the perception ... with a high-class Wellness & Spa. , The ... world’s most successful medical tourism agencies and ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 Healthpointe ... brain injuries with the help of their licensed clinical ... traumatic brain injuries can lead to an extensive array ... these effects can arise at any time after a ... be caused by any bump or jolt to the ...
(Date:5/29/2015)... Arlington, VA (PRWEB) May 29, 2015 ... into a new U.S. headquarters and a larger team, ... market and increase CloverETL's market share in the U.S. ... of the Javlin Group, achieved significant growth in 2014 ... sales of Javlin’s premier data integration platform, CloverETL. To ...
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American Society ... May 14-19th. This global event sets a gold standard ... dedicating itself exclusively to cosmetic medicine. Dr. Paul Vitenas ... to attend this year’s meeting. , Among the classes and ... the honor of sitting at the presenter’s table during a ...
(Date:5/29/2015)... Healthpointe is excited to announce that ... at their clinics in Orange County. The Supartz Therapy ... in diminishing pain for patients with osteoarthritis, and will ... Dr. Neil Katz of Healthpointe. Supartz is an injection ... as hyaluronic acid) a natural substance found in joint ...
Breaking Medicine News(10 mins):Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 2Health News:Croatian Cosmetic Dentistry Providers New Approach to Revolutionize Cosmetic Dentistry 3Health News:Healthpointe’s Los Angeles County Clinics Are Now Offering Treatment for Mild Traumatic Brain Injuries 2Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:Healthpointe is Now Offering Supartz Joint Fluid Therapy at their Anaheim Clinic and La Mirada Clinic. 2
... Perrigo Company,(Nasdaq: PRGO ; TASE) today ... dividend of $0.05 per share, payable on June ... 2008., Perrigo Company is a leading global ... and prescription,pharmaceuticals, nutritional products, active pharmaceutical ingredients,(API) and ...
... LAVAL, QC, May 1 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... its first quarter,fiscal 2008 results conference call and Annual ... On Thursday, May 8 at 8:30 a.m. (ET) ... quarter 2008 financial results. Labopharm will,report its first quarter ...
... Proven Efficacy in all Four ... Chambers of the Heart, Stereotaxis to Introduce Major New Software Platform for ... ... (Nasdaq:,STXS), announced today that approximately 15,000 procedures have been,performed using Stereotaxis, Niobe(R) Magnetic Navigation ...
... 1 /PRNewswire-FirstCall/ - Novadaq(R) Technologies Inc.,(TSX: NDQ), a developer ... operating room, will host a conference call and live,webcast ... to discuss the financial,results for the first quarter ended ... by telephone, dial 416-644-3422 or,1-800-731-5319. Please connect approximately ten ...
... published in the May 2008 edition of Otolaryngology ... several areas of hearing health, including research that indicates ... having cochlear implants placed in both ears, rather than ... are being released in conjunction with Better Hearing and ...
... Declines in Ozone and Particle Pollution Have,Stalled, ... its annual report card on air pollution today, ... short-term particle,pollution, year-round particle pollution and ozone pollution. ... Pittsburgh, Pennsylvania, tops one of,the most polluted lists ...
Cached Medicine News:Health News:Labopharm announces details for first quarter results conference call and annual meeting 2Health News:Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases 2Health News:Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases 3Health News:Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases 4Health News:Novadaq to hold first quarter 2008 results conference call and webcast 2Health News:Novadaq to hold first quarter 2008 results conference call and webcast 3Health News:New research on hearing health underscores the importance of better hearing and speech month 2Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 2Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 3Health News:American Lung Association Issues State of the Air Report: First City Outside California (Pittsburgh) Tops One of the Most-Polluted Lists 4
(Date:5/28/2015)... May 28, 2015 Henry Schein ... provider of health care products and services to ... reminded its customers that the Henry Schein Disaster ... veterinarians who experience operational, logistical or financial issues ... the South Central region of the U.S. The ...
(Date:5/28/2015)... This report analyzes the worldwide markets for Intraocular ... Segments: Standard Intraocular Lenses, and Premium Intraocular Lenses. The report ... , Japan , Europe ... America , and Rest of World. Annual estimates and ... a seven-year historic analysis is provided for these markets. Market ...
(Date:5/28/2015)... 28, 2015 KaloBios Pharmaceuticals, Inc. (Nasdaq: ... A. Martell , to the position of Executive Chairman. ... KaloBios Board of Directors. In this new role, he ... to refine and execute on the strategic plan to ... therapeutics for orphan oncology indications with high unmet medical ...
Breaking Medicine Technology:Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3World Intraocular Lenses Industry 2World Intraocular Lenses Industry 3World Intraocular Lenses Industry 4World Intraocular Lenses Industry 5World Intraocular Lenses Industry 6World Intraocular Lenses Industry 7World Intraocular Lenses Industry 8World Intraocular Lenses Industry 9World Intraocular Lenses Industry 10World Intraocular Lenses Industry 11World Intraocular Lenses Industry 12World Intraocular Lenses Industry 13World Intraocular Lenses Industry 14World Intraocular Lenses Industry 15World Intraocular Lenses Industry 16World Intraocular Lenses Industry 17World Intraocular Lenses Industry 18World Intraocular Lenses Industry 19World Intraocular Lenses Industry 20World Intraocular Lenses Industry 21World Intraocular Lenses Industry 22World Intraocular Lenses Industry 23World Intraocular Lenses Industry 24World Intraocular Lenses Industry 25World Intraocular Lenses Industry 26KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5
... years after the identification of,the gene responsible for ... a team of Spanish and French researchers (Carlos,Lopez-Otin ... Nicolas Levy and coll. -,Inserm/AP-HM, Marseille, France) have ... This treatment, combining two existing,pharmacological molecules, should slow ...
... Evaluating the, Anti-Tumor Activity of Bavituximab in Combination with Carboplatin ... ... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that patient screening,and ... safety,and efficacy of bavituximab in combination with chemotherapy in patients,with non-small cell ...
Cached Medicine Technology:Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: